Enhanced External Counterpulsation for Ischemic Heart Disease: a Look Behind the Curtain

Overview

Journal Exerc Sport Sci Rev

Specialty Orthopedics

Date 2012 Mar 13

PMID 22407185

Citations 18

Authors

Randy W Braith

Darren P Casey

Darren T Beck

Affiliations

Soon will be listed here.

Abstract

Enhanced external counterpulsation (EECP) is a noninvasive treatment for patients with coronary artery disease who have angina pectoris that is refractory to pharmacotherapy and revascularization. The popular concept is that EECP may promote collateral development and improve myocardial perfusion. We hypothesize that improvements in peripheral arterial function are responsible for the clinical benefits of EECP.

Citing Articles

Effects of single and multiple sessions of lower body diastole-synchronized compressions using a pulsating pneumatic suit on endothelium function and metabolic parameters in patients with type 2 diabetes: two controlled cross-over studies.

Valensi P, Barber-Chamoux N, Rezki A, Lambert C, Pereira B, Duale C Cardiovasc Diabetol. 2022; 21(1):286.

PMID: 36550568 PMC: 9784294. DOI: 10.1186/s12933-022-01710-6.

Predictors of adherence of enhanced external counterpulsation in patients with coronary heart disease after discharge: A mixed-methods study.

Yin Y, He Q, Zhang R, Cheng H, Zhang Y, Zhang J Front Cardiovasc Med. 2022; 9:1005958.

PMID: 36505377 PMC: 9732892. DOI: 10.3389/fcvm.2022.1005958.

Enhanced External Counterpulsation Effects on Venous Leg Symptoms.

Cuglan B, Turhan H, Yetkin E Anatol J Cardiol. 2022; 26(5):401-406.

PMID: 35552177 PMC: 9366413. DOI: 10.5152/AnatolJCardiol.2022.1350.

Case Series: Extracorporeal Shockwave Myocardial Revascularization Therapy Improves Ischemic Response, Functional Capacity, and Quality of Life in Indicated CABG-Stable Angina Pectoris Patients.

Akbar M, Adiputro D, Tiksnadi B, Soeriadi E, Hasan M, Muttaqien F Front Cardiovasc Med. 2022; 9:799834.

PMID: 35224043 PMC: 8874125. DOI: 10.3389/fcvm.2022.799834.

External Counterpulsation Improves Angiogenesis by Preserving Vascular Endothelial Growth Factor-A and Vascular Endothelial Growth Factor Receptor-2 but Not Regulating MicroRNA-92a Expression in Patients With Refractory Angina.

Ambari A, Lilihata G, Zuhri E, Ekawati E, Wijaya S, Dwiputra B Front Cardiovasc Med. 2021; 8:761112.

PMID: 34760951 PMC: 8573065. DOI: 10.3389/fcvm.2021.761112.

References

Michaels A, Accad M, Ports T, Grossman W . Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation. 2002; 106(10):1237-42. DOI: 10.1161/01.cir.0000028336.95629.b0. View

Casey D, Beck D, Nichols W, Conti C, Choi C, Khuddus M . Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris. Am J Cardiol. 2011; 107(10):1466-72. PMC: 3087864. DOI: 10.1016/j.amjcard.2011.01.021. View

Maeda S, Miyauchi T, Iemitsu M, Sugawara J, Nagata Y, Goto K . Resistance exercise training reduces plasma endothelin-1 concentration in healthy young humans. J Cardiovasc Pharmacol. 2005; 44 Suppl 1:S443-6. DOI: 10.1097/01.fjc.0000166319.91623.b0. View

Harrison D, Widder J, Grumbach I, Chen W, Weber M, Searles C . Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med. 2006; 259(4):351-63. DOI: 10.1111/j.1365-2796.2006.01621.x. View

Soran O, Kennard E, Kfoury A, Kelsey S . Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol. 2005; 97(1):17-20. DOI: 10.1016/j.amjcard.2005.07.122. View

Postadzhiyan A, Tzontcheva A, Kehayov I, Finkov B . Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem. 2007; 41(3):126-33. DOI: 10.1016/j.clinbiochem.2007.09.001. View

Zhang Y, He X, Chen X, Ma H, Liu D, Luo J . Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007; 116(5):526-34. DOI: 10.1161/CIRCULATIONAHA.106.647248. View

Chen C, Nevo E, Fetics B, Pak P, Yin F, Maughan W . Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997; 95(7):1827-36. DOI: 10.1161/01.cir.95.7.1827. View

Novo G, Bagger J, Carta R, Koutroulis G, Hall R, Nihoyannopoulos P . Enhanced external counterpulsation for treatment of refractory angina pectoris. J Cardiovasc Med (Hagerstown). 2006; 7(5):335-9. DOI: 10.2459/01.JCM.0000223255.24309.fa. View

10.

Braith R, Conti C, Nichols W, Choi C, Khuddus M, Beck D . Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010; 122(16):1612-20. PMC: 2963100. DOI: 10.1161/CIRCULATIONAHA.109.923482. View

11.

Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y . Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis. 2005; 184(2):425-30. DOI: 10.1016/j.atherosclerosis.2005.05.008. View

12.

Nichols W, Singh B . Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 2002; 17(5):543-51. DOI: 10.1097/00001573-200209000-00016. View

13.

Arora R, Chou T, Jain D, Fleishman B, Crawford L, McKiernan T . The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999; 33(7):1833-40. DOI: 10.1016/s0735-1097(99)00140-0. View

14.

Martin J, Casey D, Gurovich A, Beck D, Braith R . Association of age with timing and amplitude of reflected pressure waves during exercise in men. Am J Hypertens. 2011; 24(4):415-20. DOI: 10.1038/ajh.2010.261. View

15.

Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View

16.

Lawson W, Hui J, Lang G . Treatment benefit in the enhanced external counterpulsation consortium. Cardiology. 2000; 94(1):31-5. DOI: 10.1159/000007043. View

17.

Ridker P, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E . Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101(18):2149-53. DOI: 10.1161/01.cir.101.18.2149. View

18.

Montuschi P, Barnes P, Roberts 2nd L . Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004; 18(15):1791-800. DOI: 10.1096/fj.04-2330rev. View

19.

BIRTWELL W, Giron F, Ruiz U, Norton R, SOROFF H . The regional hemodynamic response to synchronous external pressure assist. Trans Am Soc Artif Intern Organs. 1970; 16:462-5. View

20.

Vlachopoulos C, Aznaouridis K, Stefanadis C . Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55(13):1318-27. DOI: 10.1016/j.jacc.2009.10.061. View